Zobrazeno 1 - 10
of 440
pro vyhledávání: '"D H, van Thiel"'
Autor:
M. George, O. Iqbal, Ambar Farooqui, Bharathi Daravath, Fakiha Siddiqui, D. H. Van Thiel, Cassie Bacher, D. A. Hoppensteadt, J. Fareed
Publikováno v:
65th Annual Meeting of the Society of Thrombosis and Haemostasis Research.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aef0acc825d5b7d8866bc4b1da81fc02
https://doi.org/10.1055/s-0041-1728156
https://doi.org/10.1055/s-0041-1728156
Autor:
G. Ramadori, Ahmad Amanzada, Federico Moriconi, D. H. van Thiel, Armin D Goralczyk, Alexander Lindhorst, Simon Schneider, Sabine Mihm
Publikováno v:
Digestion. 86:218-227
Background: Chronic hepatitis C virus genotype 1 (HCV-G1) infection is treated with pegylated interferon-α and ribavirin. Predictive factors for treatment success are even more important now as direct-acting antiviral agents are available. Methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa80d11e14563b0f6d89e77be0fa11a7
https://doi.org/10.1159/000339879
https://doi.org/10.1159/000339879
Autor:
Shilun D. Li, Ali Naji Aziz, L. Murphy, S. Dhillon, A. Beesla, A. Dosanjh, Christopher M. Moore, D. H. van Thiel, A. Kakar
Publikováno v:
Digestive Diseases and Sciences. 57:215-220
Hepatitis B virus (HBV) vaccination is essential in chronic liver disease (CLD), because it can help prevent acute-on-chronic disease, which has potentially fatal complications. Unfortunately, this group has a significant proportion of HBV vaccinatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e7771164a776a4558b890d18f5903d1
https://doi.org/10.1007/s10620-011-1996-0
https://doi.org/10.1007/s10620-011-1996-0
Publikováno v:
Digestive Diseases and Sciences. 52:3275-3281
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe49385ce06400fbddba87cdf386ca44
https://doi.org/10.1007/s10620-005-9017-9
https://doi.org/10.1007/s10620-005-9017-9
Autor:
D. H. Van Thiel, N Leone, Sarah Aziz, Ali Naji Aziz, L. Murphy, S Dhillon, Marc Kennedy, D. S. Li
Publikováno v:
Journal of Viral Hepatitis. 13:217-221
Patients with chronic liver disease (CLD) respond poorly to standard hepatitis B (HBV) vaccine given as sequential 20 microg IM shots because of an overall impaired immune response. Many of these patients go on to liver transplantation and are at ris
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::321fb96509b0ae6d6c2521e201823c88
https://doi.org/10.1111/j.1365-2893.2005.00674.x
https://doi.org/10.1111/j.1365-2893.2005.00674.x
Autor:
Lawrence J. Marnett, D. H. Van Thiel, John P. Plastaras, Gary E. Hatch, Patrick B. Walter, Carol E. Parker, Samar Basu, John A. Lawson, Jay W. Heinecke, L. J. Roberts, D.M. Murray, Mark K. Shigenaga, Rajindar S. Sohal, Abraham Nyska, R.R. Tice, Kenneth B. Tomer, M. George, Maria B. Kadiiska, J. Rokach, Garret A. FitzGerald, LeRae Graham, Kenneth Hensley, Beth C. Gladen, J.C. Barrett, Ronald P. Mason, Donna D. Baird, Robert A. Floyd, Daniel Wellner, Dori R. Germolec, J.T. Wachsman, Nathan Brot, J. Sun, Jason D. Morrow, Bruce N. Ames
Publikováno v:
Free Radical Biology and Medicine. 38:698-710
Oxidation products of lipids, proteins, and DNA in the blood, plasma, and urine of rats were measured as part of a comprehensive, multilaboratory validation study searching for noninvasive biomarkers of oxidative stress. This article is the second re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::968d6e2f8af2319d8bf08db87790c5f0
https://doi.org/10.1016/j.freeradbiomed.2004.09.017
https://doi.org/10.1016/j.freeradbiomed.2004.09.017
Publikováno v:
Journal of Viral Hepatitis. 8:372-376
Hepatitis B virus (HBV) vaccination is recommended for individuals with chronic liver disease. However, the response to standard doses of hepatitis B vaccines in such individuals has been poor. The aim of the present study was to assess the response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af1595fe3fc7fb85c4bf561072f6aa96
https://doi.org/10.1046/j.1365-2893.2001.00301.x
https://doi.org/10.1046/j.1365-2893.2001.00301.x
Publikováno v:
Journal of Viral Hepatitis. 7:466-470
The role of procoagulant autoantibodies in hepatitis C virus (HCV) infection is unclear. Three individuals with HCV infection and a unique genetic hypercoagulable state developed retinal vein thrombosis (RVT) in association with interferon-alpha (IFN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c23978427eb2e84153699ae3cedde9e2
https://doi.org/10.1046/j.1365-2893.2000.00245.x
https://doi.org/10.1046/j.1365-2893.2000.00245.x
Autor:
A S, Gaweco, R H, Wiesner, S, Yong, R, Krom, M, Porayko, G, Chejfec, K D, McClatchey, D H, Van Thiel
Publikováno v:
Liver Transplantation and Surgery. 5:1-7
The CD40-CD40L (CD154) interaction plays a pivotal role in the effector mechanisms of allograft rejection. Blockade of the CD40/CD40L costimulatory pathway prevents the development of chronic allograft rejection in several animal transplant models. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1971aaba22a810e063b47cd7344a8151
https://doi.org/10.1002/lt.500050108
https://doi.org/10.1002/lt.500050108
Autor:
D. H. Van Thiel, Thomas E. Starzl, Rafael Mañez, J. J. Fung, Anthony J. Demetris, Jorge Rakela, A. C. Tsamanadas, Ashokkumar Jain
Publikováno v:
Liver Transplantation and Surgery. 4:197-203
Interferon alfa-2b (IFN-alpha) therapy has been shown to be effective in the treatment of viral hepatitis B (HBV) or viral hepatitis C (HCV) in patients who did not undergo transplantation. However, in allograft recipients, treatment with IFN-alpha o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8dd2c7bc7ceffd5ff92e3562ffb302c
https://doi.org/10.1002/lt.500040315
https://doi.org/10.1002/lt.500040315